Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Accuracy of Distal Internal Carotid Artery Contrast Ratio to Infer Proximal Carotid Disease in the Mobile Stroke Unit.

Stroke (Hoboken, N.J.)·2026

Same author

Advances in Acute Ischemic Stroke 2025: Medical Treatments.

Stroke·2026

Same author

Chinese stroke association guidelines on construction of direct transfer to angiography suite.

Stroke and vascular neurology·2026

Same author

Effects of Fibrinogen on Tenecteplase Treatment in Acute Ischaemic Stroke After 4.5 Hours of Symptom Onset: A Post Hoc Analysis of the TRACE-III Trial.

Neurology and therapy·2026

Same author

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE): protocol for an international investigator-initiated, prospective, randomised, open, blinded endpoint assessment (PROBE) interventional multi-centre trial.

European stroke journal·2026

Same author

Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.

Lancet (London, England)·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026

Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 6, 2026

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

Ischaemic stroke.

Bruce C V Campbell^1,2, Deidre A De Silva³, Malcolm R Macleod⁴

¹Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia. bruce.campbell@mh.org.au.

Nature Reviews. Disease Primers

|October 12, 2019

Summary

This summary is machine-generated.

Rapid reperfusion therapies like thrombolysis and thrombectomy significantly reduce disability from ischemic stroke. Optimizing care systems to minimize treatment delays is crucial for maximizing patient benefits and improving outcomes.

More Related Videos

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat

Published on: February 5, 2011

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

Related Experiment Videos

Last Updated: Jan 6, 2026

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat

Published on: February 5, 2011

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

Area of Science:

Neurology
Cardiovascular Medicine
Public Health

Background:

Stroke is a leading global cause of death and disability, with rising incidence in developing nations.
Ischemic stroke, caused by arterial blockage, accounts for most stroke cases.
Effective management hinges on timely reperfusion therapies to restore blood flow.

Purpose of the Study:

To highlight the critical role of rapid reperfusion in stroke management.
To emphasize the importance of reducing treatment delays for optimal patient outcomes.
To outline current and extended therapeutic windows for reperfusion interventions.

Main Methods:

Review of current clinical guidelines and evidence for stroke reperfusion therapies.
Analysis of treatment time windows for intravenous thrombolysis and endovascular thrombectomy.
Examination of secondary prevention strategies tailored to stroke etiology.

Main Results:

Intravenous thrombolysis is effective within 4.5 hours, with extended benefits up to 9 hours in selected cases.
Endovascular thrombectomy benefits patients with large vessel occlusion within 6 hours, extendable to 24 hours with imaging.
Secondary prevention involves risk factor management and mechanism-specific treatments like anticoagulation or carotid endarterectomy.

Conclusions:

Timely administration of reperfusion therapies is paramount for reducing stroke-related disability.
Expanding treatment eligibility through advanced imaging improves outcomes for a broader patient group.
Comprehensive secondary prevention strategies are essential for long-term stroke risk reduction.